These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 34512560)

  • 1. Adaptation of the Start-Growth-Time Method for High-Throughput Biofilm Quantification.
    Thieme L; Hartung A; Tramm K; Graf J; Spott R; Makarewicz O; Pletz MW
    Front Microbiol; 2021; 12():631248. PubMed ID: 34512560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Dalbavancin on Staphylococcal Biofilms When Administered Alone or in Combination With Biofilm-Detaching Compounds.
    Žiemytė M; Rodríguez-Díaz JC; Ventero MP; Mira A; Ferrer MD
    Front Microbiol; 2020; 11():553. PubMed ID: 32362877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activity of dalbavancin, alone and in combination with rifampicin, against meticillin-resistant Staphylococcus aureus in a foreign-body infection model.
    Baldoni D; Furustrand Tafin U; Aeppli S; Angevaare E; Oliva A; Haschke M; Zimmerli W; Trampuz A
    Int J Antimicrob Agents; 2013 Sep; 42(3):220-5. PubMed ID: 23880168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimization of resazurin-based viability staining for quantification of microbial biofilms.
    Van den Driessche F; Rigole P; Brackman G; Coenye T
    J Microbiol Methods; 2014 Mar; 98():31-4. PubMed ID: 24365109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro testing of a first-in-class tri-alkylnorspermidine-biaryl antibiotic in an anti-biofilm silicone coating.
    Ashton NN; Allyn G; Porter ST; Haussener TJ; Sebahar PR; Looper RE; Williams DL
    Acta Biomater; 2019 Jul; 93():25-35. PubMed ID: 30769135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dalbavancin is active in vitro against biofilms formed by dalbavancin-susceptible enterococci.
    Neudorfer K; Schmidt-Malan SM; Patel R
    Diagn Microbiol Infect Dis; 2018 Jan; 90(1):58-63. PubMed ID: 29195766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A method for high throughput determination of viable bacteria cell counts in 96-well plates.
    Hazan R; Que YA; Maura D; Rahme LG
    BMC Microbiol; 2012 Nov; 12():259. PubMed ID: 23148795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Laser-generated shockwaves enhance antibacterial activity against biofilms in vitro.
    Yao W; Kuan EC; Francis NC; St John MA; Grundfest WS; Taylor ZD
    Lasers Surg Med; 2017 Jul; 49(5):539-547. PubMed ID: 28333393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibiotic susceptibility assay for Staphylococcus aureus in biofilms developed in vitro.
    Amorena B; Gracia E; Monzón M; Leiva J; Oteiza C; Pérez M; Alabart JL; Hernández-Yago J
    J Antimicrob Chemother; 1999 Jul; 44(1):43-55. PubMed ID: 10459809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid
    Herten M; Bisdas T; Knaack D; Becker K; Osada N; Torsello GB; Idelevich EA
    Front Microbiol; 2017; 8():2333. PubMed ID: 29259580
    [No Abstract]   [Full Text] [Related]  

  • 11. Quantifying implant-associated biofilms: Comparison of microscopic, microbiologic and biochemical methods.
    Doll K; Jongsthaphongpun KL; Stumpp NS; Winkel A; Stiesch M
    J Microbiol Methods; 2016 Nov; 130():61-68. PubMed ID: 27444546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro synergism and anti-biofilm activity of ampicillin, gentamicin, ceftaroline and ceftriaxone against Enterococcus faecalis.
    Thieme L; Klinger-Strobel M; Hartung A; Stein C; Makarewicz O; Pletz MW
    J Antimicrob Chemother; 2018 Jun; 73(6):1553-1561. PubMed ID: 29506271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Susceptibility of Staphylococcus aureus biofilms to vancomycin, gemtamicin and rifampin].
    Kotulová D; Slobodníková L
    Epidemiol Mikrobiol Imunol; 2010 Apr; 59(2):80-7. PubMed ID: 20586169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microplate Alamar blue assay for Staphylococcus epidermidis biofilm susceptibility testing.
    Pettit RK; Weber CA; Kean MJ; Hoffmann H; Pettit GR; Tan R; Franks KS; Horton ML
    Antimicrob Agents Chemother; 2005 Jul; 49(7):2612-7. PubMed ID: 15980327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activity of gentamicin, vancomycin or amikacin combined with EDTA or l-arginine as lock therapy against a wide spectrum of biofilm-forming clinical strains isolated from catheter-related infections.
    Lebeaux D; Leflon-Guibout V; Ghigo JM; Beloin C
    J Antimicrob Chemother; 2015; 70(6):1704-12. PubMed ID: 25712314
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Rubia M; Cordero A; Pérez-Granda MJ; Cercenado E; Pascual C; Muñoz P; Guembe M
    Antimicrob Agents Chemother; 2020 Nov; 64(12):. PubMed ID: 32988823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of biofilm on the in vitro activity of vancomycin alone and in combination with tigecycline and rifampicin against Staphylococcus aureus.
    Rose WE; Poppens PT
    J Antimicrob Chemother; 2009 Mar; 63(3):485-8. PubMed ID: 19109338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Platform of Anti-biofilm Assays Suited to the Exploration of Natural Compound Libraries.
    Skogman ME; Vuorela PM; Fallarero A
    J Vis Exp; 2016 Dec; (118):. PubMed ID: 28060302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the in vitro activities of ceftobiprole and comparators in staphylococcal colony or microtitre plate biofilm assays.
    Abbanat D; Shang W; Amsler K; Santoro C; Baum E; Crespo-Carbone S; Lynch AS
    Int J Antimicrob Agents; 2014 Jan; 43(1):32-9. PubMed ID: 24252780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibiotic Susceptibility of Escherichia coli Cells during Early-Stage Biofilm Formation.
    Gu H; Lee SW; Carnicelli J; Jiang Z; Ren D
    J Bacteriol; 2019 Sep; 201(18):. PubMed ID: 31061169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.